This announcement is a separate document:
亨迪药业：2023年年度股东大会法律意见书
Hubei Biocause Heilen Pharmaceutical: 2023 Annual General Meeting of Shareholders Legal Opinions
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
23:41
Russia has expressed its willingness to fully cooperate with the investigation into the crash of the Azerbaijan Airlines passenger plane.
23:39
WiMi Hologram Cloud has developed a quantum technology-based random access memory structure called QRAM.
WIMI+44.19%
23:38
The USD is heading towards its best annual performance in nine years, supported by the USA economy and the threat of tariffs from Donald Trump.
USD/ZAR-0.92%
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.